CLEVELAND, Ohio — A recent clinical trial led by the University of Cincinnati looked at whether people living with HIV were ...
Add Yahoo as a preferred source to see more of our stories on Google. AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the ...
A recent study has found that lenacapavir, an injectable medication administered twice a year, is more effective at preventing HIV among gay, bisexual, and transgender people than a daily regimen of ...
ZUG, Switzerland--(BUSINESS WIRE)--Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight loss on the skin and the importance of ...
HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Participants Remaining HIV Negative Gilead Launches ...
A medication offered to heroin abusers at the Albany County jail was shown to help prevent addicts from returning to illegal drug use, according to a study published Wednesday in the New England ...
The Food and Drug Administration (FDA) approved an injectable medication to be used as an HIV prevention drug on Wednesday. People would only need to use the drug every six months, or twice a year, ...
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
SEATTLE — Computer scientists and doctors at the University of Washington have found a way for artificial intelligence to deter a concerning incidence in healthcare: medication errors. Errors in ...
Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results